LIBERTY LATIN AMERIC-CL C (LILAK) Fundamental Analysis & Valuation

NASDAQ:LILAK • BMG9001E1286

Current stock price

8.32 USD
+0.07 (+0.85%)
At close:
8.32 USD
0 (0%)
After Hours:

This LILAK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. LILAK Profitability Analysis

1.1 Basic Checks

  • LILAK had negative earnings in the past year.
  • LILAK had a positive operating cash flow in the past year.
  • In the past 5 years LILAK always reported negative net income.
  • Each year in the past 5 years LILAK had a positive operating cash flow.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • LILAK has a Return On Assets of -5.00%. This is in the lower half of the industry: LILAK underperforms 67.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -110.01%, LILAK is doing worse than 86.49% of the companies in the same industry.
  • LILAK has a Return On Invested Capital of 5.60%. This is in the better half of the industry: LILAK outperforms 72.97% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LILAK is in line with the industry average of 5.91%.
  • The 3 year average ROIC (4.52%) for LILAK is below the current ROIC(5.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -5%
ROE -110.01%
ROIC 5.6%
ROA(3y)-3.64%
ROA(5y)-3.02%
ROE(3y)-59.17%
ROE(5y)-41.28%
ROIC(3y)4.52%
ROIC(5y)4.5%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

  • LILAK has a Operating Margin of 16.35%. This is in the better half of the industry: LILAK outperforms 62.16% of its industry peers.
  • LILAK's Operating Margin has improved in the last couple of years.
  • The Gross Margin of LILAK (78.03%) is better than 94.59% of its industry peers.
  • LILAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.35%
PM (TTM) N/A
GM 78.03%
OM growth 3Y3.35%
OM growth 5Y6.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y0.2%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

2

2. LILAK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LILAK is destroying value.
  • Compared to 1 year ago, LILAK has more shares outstanding
  • Compared to 5 years ago, LILAK has less shares outstanding
  • Compared to 1 year ago, LILAK has a worse debt to assets ratio.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.19, we must say that LILAK is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of LILAK (0.19) is worse than 75.68% of its industry peers.
  • The Debt to FCF ratio of LILAK is 27.07, which is on the high side as it means it would take LILAK, 27.07 years of fcf income to pay off all of its debts.
  • LILAK has a Debt to FCF ratio of 27.07. This is comparable to the rest of the industry: LILAK outperforms 45.95% of its industry peers.
  • A Debt/Equity ratio of 14.17 is on the high side and indicates that LILAK has dependencies on debt financing.
  • LILAK has a worse Debt to Equity ratio (14.17) than 83.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 14.17
Debt/FCF 27.07
Altman-Z 0.19
ROIC/WACC0.81
WACC6.95%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • LILAK has a Current Ratio of 1.14. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of LILAK (1.14) is comparable to the rest of the industry.
  • LILAK has a Quick Ratio of 1.14. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.14, LILAK perfoms like the industry average, outperforming 54.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

3

3. LILAK Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.38% over the past year.
  • The Revenue has decreased by -0.33% in the past year.
  • Measured over the past years, LILAK shows a small growth in Revenue. The Revenue has been growing by 3.27% on average per year.
EPS 1Y (TTM)8.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)-0.33%
Revenue growth 3Y-2.65%
Revenue growth 5Y3.27%
Sales Q2Q%0.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.13% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LILAK will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y95.89%
EPS Next 2Y46.29%
EPS Next 3Y28.13%
EPS Next 5YN/A
Revenue Next Year-2.7%
Revenue Next 2Y2.25%
Revenue Next 3Y2.53%
Revenue Next 5Y2.7%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2 -3

3

4. LILAK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LILAK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • 78.38% of the companies in the same industry are more expensive than LILAK, based on the Enterprise Value to EBITDA ratio.
  • 91.89% of the companies in the same industry are more expensive than LILAK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.44
EV/EBITDA 5.62
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

  • LILAK's earnings are expected to grow with 28.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.29%
EPS Next 3Y28.13%

0

5. LILAK Dividend Analysis

5.1 Amount

  • No dividends for LILAK!.
Industry RankSector Rank
Dividend Yield 0%

LILAK Fundamentals: All Metrics, Ratios and Statistics

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (3/24/2026, 8:00:02 PM)

After market: 8.32 0 (0%)

8.32

+0.07 (+0.85%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-18
Earnings (Next)05-05
Inst Owners68.34%
Inst Owner Change-1.99%
Ins Owners11.57%
Ins Owner ChangeN/A
Market Cap1.66B
Revenue(TTM)4.44B
Net Income(TTM)-611.20M
Analysts77.78
Price Target10.06 (20.91%)
Short Float %15.11%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-215.8%
Min EPS beat(2)-561.76%
Max EPS beat(2)130.17%
EPS beat(4)1
Avg EPS beat(4)-1446.66%
Min EPS beat(4)-4518.74%
Max EPS beat(4)130.17%
EPS beat(8)2
Avg EPS beat(8)-5836.53%
EPS beat(12)4
Avg EPS beat(12)-4087.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.04%
Min Revenue beat(2)-0.13%
Max Revenue beat(2)0.22%
Revenue beat(4)1
Avg Revenue beat(4)-1.86%
Min Revenue beat(4)-4.03%
Max Revenue beat(4)0.22%
Revenue beat(8)1
Avg Revenue beat(8)-2.52%
Revenue beat(12)1
Avg Revenue beat(12)-2.83%
Revenue beat(16)1
Avg Revenue beat(16)-2.72%
PT rev (1m)0.34%
PT rev (3m)0.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-131.26%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF 5.44
P/OCF 2.07
P/B 3
P/tB N/A
EV/EBITDA 5.62
EPS(TTM)-3.06
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)1.53
FCFY18.37%
OCF(TTM)4.03
OCFY48.41%
SpS22.2
BVpS2.78
TBVpS-20.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5%
ROE -110.01%
ROCE 7.09%
ROIC 5.6%
ROICexc 6.06%
ROICexgc 12.01%
OM 16.35%
PM (TTM) N/A
GM 78.03%
FCFM 6.89%
ROA(3y)-3.64%
ROA(5y)-3.02%
ROE(3y)-59.17%
ROE(5y)-41.28%
ROIC(3y)4.52%
ROIC(5y)4.5%
ROICexc(3y)4.88%
ROICexc(5y)4.85%
ROICexgc(3y)10.06%
ROICexgc(5y)9.91%
ROCE(3y)5.72%
ROCE(5y)5.69%
ROICexgc growth 3Y4.35%
ROICexgc growth 5Y11.66%
ROICexc growth 3Y5.88%
ROICexc growth 5Y15.71%
OM growth 3Y3.35%
OM growth 5Y6.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y0.2%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 14.17
Debt/FCF 27.07
Debt/EBITDA 4.82
Cap/Depr 55.25%
Cap/Sales 11.26%
Interest Coverage 1.21
Cash Conversion 49.4%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 0.19
F-Score6
WACC6.95%
ROIC/WACC0.81
Cap/Depr(3y)56.36%
Cap/Depr(5y)63.58%
Cap/Sales(3y)12.13%
Cap/Sales(5y)13.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y95.89%
EPS Next 2Y46.29%
EPS Next 3Y28.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.33%
Revenue growth 3Y-2.65%
Revenue growth 5Y3.27%
Sales Q2Q%0.8%
Revenue Next Year-2.7%
Revenue Next 2Y2.25%
Revenue Next 3Y2.53%
Revenue Next 5Y2.7%
EBIT growth 1Y34.17%
EBIT growth 3Y0.61%
EBIT growth 5Y9.47%
EBIT Next Year1079.04%
EBIT Next 3Y140.16%
EBIT Next 5YN/A
FCF growth 1Y41.69%
FCF growth 3Y13.59%
FCF growth 5Y32.71%
OCF growth 1Y6.56%
OCF growth 3Y-2.47%
OCF growth 5Y4.71%

LIBERTY LATIN AMERIC-CL C / LILAK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LIBERTY LATIN AMERIC-CL C?

ChartMill assigns a fundamental rating of 3 / 10 to LILAK.


What is the valuation status for LILAK stock?

ChartMill assigns a valuation rating of 3 / 10 to LIBERTY LATIN AMERIC-CL C (LILAK). This can be considered as Overvalued.


How profitable is LIBERTY LATIN AMERIC-CL C (LILAK) stock?

LIBERTY LATIN AMERIC-CL C (LILAK) has a profitability rating of 4 / 10.


Is the dividend of LIBERTY LATIN AMERIC-CL C sustainable?

The dividend rating of LIBERTY LATIN AMERIC-CL C (LILAK) is 0 / 10 and the dividend payout ratio is 0%.